Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 151

1.

VEGFA and VEGFR2 gene polymorphisms and response to anti-vascular endothelial growth factor therapy: comparison of age-related macular degeneration treatments trials (CATT).

Hagstrom SA, Ying GS, Pauer GJ, Sturgill-Short GM, Huang J, Maguire MG, Martin DF; Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) Research Group.

JAMA Ophthalmol. 2014 May;132(5):521-7.

PMID:
24652518
[PubMed - indexed for MEDLINE]
2.

Co-administration of resveratrol and lipoic acid, or their synthetic combination, enhances neuroprotection in a rat model of ischemia/reperfusion.

Saleh MC, Connell BJ, Rajagopal D, Khan BV, Abd-El-Aziz AS, Kucukkaya I, Saleh TM.

PLoS One. 2014 Jan 31;9(1):e87865. doi: 10.1371/journal.pone.0087865. eCollection 2014.

PMID:
24498217
[PubMed - in process]
Free PMC Article
3.

A comparison of lamellar and penetrating keratoplasty outcomes: a registry study.

Coster DJ, Lowe MT, Keane MC, Williams KA; Australian Corneal Graft Registry Contributors.

Ophthalmology. 2014 May;121(5):979-87. doi: 10.1016/j.ophtha.2013.12.017. Epub 2014 Feb 1.

PMID:
24491643
[PubMed - indexed for MEDLINE]
4.

UPEI-300, a conjugate of lipoic acid and edaravone, mediates neuroprotection in ischemia/reperfusion.

Connell BJ, Saleh MC, Kucukkaya I, Abd-El-Aziz AS, Khan BV, Saleh TM.

Neurosci Lett. 2014 Feb 21;561:151-5. doi: 10.1016/j.neulet.2013.12.060. Epub 2014 Jan 3.

PMID:
24394910
[PubMed - in process]
5.

Human immunodeficiency virus and heparan sulfate: from attachment to entry inhibition.

Connell BJ, Lortat-Jacob H.

Front Immunol. 2013 Nov 20;4:385. doi: 10.3389/fimmu.2013.00385. Review.

PMID:
24312095
[PubMed]
Free PMC Article
6.

Resveratrol induced neuroprotection is mediated via both estrogen receptor subtypes, ER(α) and ER(β).

Saleh MC, Connell BJ, Saleh TM.

Neurosci Lett. 2013 Aug 26;548:217-21. doi: 10.1016/j.neulet.2013.05.057. Epub 2013 Jun 5.

PMID:
23748073
[PubMed - indexed for MEDLINE]
7.

Macular morphology and visual acuity in the comparison of age-related macular degeneration treatments trials.

Jaffe GJ, Martin DF, Toth CA, Daniel E, Maguire MG, Ying GS, Grunwald JE, Huang J; Comparison of Age-related Macular Degeneration Treatments Trials Research Group.

Ophthalmology. 2013 Sep;120(9):1860-70. doi: 10.1016/j.ophtha.2013.01.073. Epub 2013 May 1.

PMID:
23642377
[PubMed - indexed for MEDLINE]
8.

Reflections 1 year into the 21-Center National Institutes of Health--funded WRIST study: a primer on conducting a multicenter clinical trial.

Wrist and Radius Injury Surgical Trial (WRIST) Study Group.

J Hand Surg Am. 2013 Jun;38(6):1194-201. doi: 10.1016/j.jhsa.2013.02.027. Epub 2013 Apr 20. Erratum in: J Hand Surg Am. 2013 Aug;38(8):1662.

PMID:
23608306
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Peripheral hypertrophic subepithelial corneal degeneration: nomenclature, phenotypes, and long-term outcomes.

Gore DM, Iovieno A, Connell BJ, Alexander R, Meligonis G, Dart JK.

Ophthalmology. 2013 May;120(5):892-8. doi: 10.1016/j.ophtha.2012.10.037. Epub 2013 Mar 6.

PMID:
23474249
[PubMed - indexed for MEDLINE]
10.

Contact lens management of keratoconus in a patient with residual astigmatism resulting from implantation of a toric intraocular lens.

Lindsay RG, Connell BJ, Snibson GR.

Clin Exp Optom. 2013 Mar;96(2):238-41. doi: 10.1111/cxo.12036. Epub 2013 Feb 18.

PMID:
23414236
[PubMed - indexed for MEDLINE]
11.

Pharmacogenetics for genes associated with age-related macular degeneration in the Comparison of AMD Treatments Trials (CATT).

Hagstrom SA, Ying GS, Pauer GJ, Sturgill-Short GM, Huang J, Callanan DG, Kim IK, Klein ML, Maguire MG, Martin DF; Comparison of AMD Treatments Trials Research Group.

Ophthalmology. 2013 Mar;120(3):593-9. doi: 10.1016/j.ophtha.2012.11.037. Epub 2013 Jan 18.

PMID:
23337555
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Endothelial stress products and coagulation markers in patients with multiple myeloma treated with lenalidomide plus dexamethasone: an observational study.

Rosovsky R, Hong F, Tocco D, Connell B, Mitsiades C, Schlossman R, Ghobrial I, Lockridge L, Warren D, Bradwin G, Doyle M, Munshi N, Soiffer RJ, Anderson KC, Weller E, Richardson P.

Br J Haematol. 2013 Feb;160(3):351-8. doi: 10.1111/bjh.12152. Epub 2012 Dec 13.

PMID:
23240658
[PubMed - indexed for MEDLINE]
13.

Guanosine protects against reperfusion injury in rat brains after ischemic stroke.

Connell BJ, Di Iorio P, Sayeed I, Ballerini P, Saleh MC, Giuliani P, Saleh TM, Rathbone MP, Su C, Jiang S.

J Neurosci Res. 2013 Feb;91(2):262-72. doi: 10.1002/jnr.23156. Epub 2012 Nov 14.

PMID:
23151946
[PubMed - indexed for MEDLINE]
14.

Baseline predictors for one-year visual outcomes with ranibizumab or bevacizumab for neovascular age-related macular degeneration.

Ying GS, Huang J, Maguire MG, Jaffe GJ, Grunwald JE, Toth C, Daniel E, Klein M, Pieramici D, Wells J, Martin DF; Comparison of Age-related Macular Degeneration Treatments Trials Research Group.

Ophthalmology. 2013 Jan;120(1):122-9. doi: 10.1016/j.ophtha.2012.07.042. Epub 2012 Oct 6.

PMID:
23047002
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results.

Comparison of Age-related Macular Degeneration Treatments Trials (CATT) Research Group, Martin DF, Maguire MG, Fine SL, Ying GS, Jaffe GJ, Grunwald JE, Toth C, Redford M, Ferris FL 3rd.

Ophthalmology. 2012 Jul;119(7):1388-98. doi: 10.1016/j.ophtha.2012.03.053. Epub 2012 May 1.

PMID:
22555112
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Heterogeneous reactions of epoxides in acidic media.

Lal V, Khalizov AF, Lin Y, Galvan MD, Connell BT, Zhang R.

J Phys Chem A. 2012 Jun 21;116(24):6078-90. doi: 10.1021/jp2112704. Epub 2012 Mar 2.

PMID:
22309032
[PubMed]
17.

A synthetic heparan sulfate-mimetic peptide conjugated to a mini CD4 displays very high anti- HIV-1 activity independently of coreceptor usage.

Connell BJ, Baleux F, Coic YM, Clayette P, Bonnaffé D, Lortat-Jacob H.

Chem Biol. 2012 Jan 27;19(1):131-9. doi: 10.1016/j.chembiol.2011.12.009.

PMID:
22284360
[PubMed - indexed for MEDLINE]
Free Article
18.

UPEI-100, a conjugate of lipoic acid and apocynin, mediates neuroprotection in a rat model of ischemia/reperfusion.

Connell BJ, Saleh MC, Khan BV, Rajagopal D, Saleh TM.

Am J Physiol Regul Integr Comp Physiol. 2012 Apr;302(7):R886-95. doi: 10.​1152/​ajpregu.​00644.​2011. Epub 2012 Jan 25.

PMID:
22277933
[PubMed - indexed for MEDLINE]
19.

Novel Neurovascular Protective Agents: Effects of INV-155, INV-157, INV-159, and INV-161 versus Lipoic Acid and Captopril in a Rat Stroke Model.

Connell BJ, Khan BV, Rajagopal D, Saleh TM.

Cardiol Res Pract. 2012;2012:319230. doi: 10.1155/2012/319230. Epub 2012 Jan 4.

PMID:
22263115
[PubMed]
Free PMC Article
20.

Co-administration of apocynin with lipoic acid enhances neuroprotection in a rat model of ischemia/reperfusion.

Connell BJ, Saleh TM.

Neurosci Lett. 2012 Jan 17;507(1):43-6. doi: 10.1016/j.neulet.2011.11.047. Epub 2011 Dec 6.

PMID:
22155048
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk